Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Apple
AAPL
AU Stock MarketDetailed Quotes
IXC Invex Therapeutics Ltd
- 0.081
- +0.006+8.00%
20min DelayNot Open Apr 30 15:31 AET
6.09MMarket Cap-3.68P/E (Static)
0.082High0.079Low34.04KVolume0.079Open0.075Pre Close2.70KTurnover0.09052wk High0.07%Turnover Ratio75.15MShares0.05952wk Low-0.022EPS TTM3.90MFloat Cap0.522Historical HighLossP/E (Static)48.16MShs Float0.038Historical Low-0.022EPS LYR4.00%Amplitude0.19Dividend TTM1.13P/B1Lot Size229.63%Div YieldTTM
About Invex Therapeutics Ltd Company
Invex Therapeutics Ltd is a biopharmaceutical company, focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised ICP including TBI, stroke and hydrocephalus. In addition, the Group has generated early-stage data on the use of Exenatide in the treatment of glaucoma, through the lowering of intraocular pressure in the eye. Geographically, it operates only in Australia.
Company Profile
SymbolIXC
Company NameInvex Therapeutics Ltd
Founded2019
MarketASX
Fiscal Year Ends06-30
Address38 Rowland Street Level 1
CitySubiaco
CountryAustralia
Zip Code6008
Phone+61 863820137
Share RegistryAUTOMIC REGISTRY SERVICES
LEVEL 5, 191 St Georges Terrace,, PERTH, WA, AUSTRALIA, 6000
(08) 9324 2099
Company Executives
- Name
- Position
- Salary
- Thomas (Tom) Duthy
- Executive Director
- --
- David McAuliffe
- Non-Executive Director
- --
- David Colin Wheeler
- Non-Executive Director
- --
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts